With the Kaplan–Meier Plotter analysis, the expression of CXCL2 in pancreatic cancer significantly affects the prognosis of patients (n = 177), and high expression levels are associated with a poor prognosis (Fig. 7B). The gene discussed is CXCL2; the disease is pancreatic neoplasm.